[HTML][HTML] Next generation probiotics in disease amelioration

CJ Chang, TL Lin, YL Tsai, TR Wu, WF Lai… - Journal of food and drug …, 2019 - Elsevier
Studies on the role of gut commensal bacteria in health development have rapidly attracted
much more attention beyond the classical pathogens over the last decade. Many important …

Next-generation probiotics: a promising approach towards designing personalized medicine

TP Singh, BH Natraj - Critical Reviews in Microbiology, 2021 - Taylor & Francis
Second brain, forgotten organ, individual's identity card, and host's fingerprint are the few
collective terms that are often used to describe the gut microbiome because of its variability …

CCR5-edited gene therapies for HIV cure: Closing the door to viral entry

KG Haworth, CW Peterson, HP Kiem - Cytotherapy, 2017 - Elsevier
Human immunodeficiency virus (HIV) was first reported and characterized more than three
decades ago. Once thought of as a death sentence, HIV infection has become a chronically …

[HTML][HTML] Acute myeloid leukemia in patients living with HIV infection: several questions, fewer answers

F Forghieri, V Nasillo, F Bettelli, V Pioli, D Giusti… - International Journal of …, 2020 - mdpi.com
Both human immunodeficiency virus (HIV) infection and acute myeloid leukemia (AML) may
be considered relatively uncommon disorders in the general population, but the precise …

Haematopoietic stem-cell transplantation in an HIV endemic area: time to consider donors exposed to or living with HIV

CL Hendricks, J Mellet, C Durandt, D Brittain… - The Lancet …, 2023 - thelancet.com
South Africa has more than 8 million people living with HIV. However, the number of patients
undergoing haematopoietic stem-cell transplantation (HSCT) in South Africa is far below the …

Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders

M Kwon, R Bailén, P Balsalobre, M Jurado… - Aids, 2019 - journals.lww.com
Methods: We retrospectively reviewed 22 HIV-positive patients who received allogeneic
HSCT in five centers in Spain. Results: A total of 22 patients with high-risk hematological …

[HTML][HTML] Risks and outcomes of allogeneic hematopoietic stem cell transplantation for hematologic malignancies in patients with HIV infection

S Arslan, MR Litzow, NW Cummins, SA Rizza… - Biology of Blood and …, 2019 - Elsevier
Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative therapy for
hematologic malignancies in persons living with HIV (PLHIV), however, uncertainties exist in …

From Berlin to London: HIV-1 reservoir reduction following stem cell transplantation

CA Prator, J Donatelli, TJ Henrich - Current HIV/AIDS Reports, 2020 - Springer
Abstract Purpose of Review Few interventional strategies lead to significant reductions in
HIV-1 reservoir size or prolonged antiretroviral (ART)-free remission. Allogeneic stem cell …

Drug interactions in the treatment of malignancy in HIV-infected patients

T Welz, C Wyen, M Hensel - Oncology Research and Treatment, 2017 - karger.com
The number of patients with HIV (human immunodeficiency virus) requiring treatment for
malignancy is increasing worldwide. Concurrent treatment of HIV and malignancy is …

How I treat patients with HIV-related hematological malignancies using hematopoietic cell transplantation

JC Alvarnas, JA Zaia, SJ Forman - Blood, The Journal of the …, 2017 - ashpublications.org
Hematopoietic cell transplantation (HCT) has now been shown to be safe and effective for
selected HIV-infected patients with hematological malignancies. Autologous HCT is now the …